Day: April 19, 2021

InterDigital Nominates Pierre-Yves Lesaicherre to Board of Directors

WILMINGTON, Del., April 19, 2021 (GLOBE NEWSWIRE) — InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced the nomination of Pierre-Yves Lesaicherre for election to the company’s Board of Directors at the company’s annual shareholder meeting scheduled for June 2, 2021. Dr. Lesaicherre is an executive with leading experience in semiconductors and a strong background in technology, science and global business. Dr. Lesaicherre was the President, Chief Executive Officer and Director of Nanometrics Incorporated, a leading provider of advanced process control metrology and software analytics, from 2017 to 2019. Prior to his tenure at Nanometrics, Dr. Lesaicherre was the CEO of Lumileds, an integrated manufacturer of LED components and automotive lighting lamps, starting in 2012....

Continue reading

International Money Express, Inc. to Release First Quarter 2021 Earnings

MIAMI, April 19, 2021 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (the “Company”), will release First Quarter 2021 earnings before the start of trading on Wednesday, May 5, 2021. Management will host a conference call on May 5, 2021, at 8:30 am ET to discuss the company’s financial results. The conference call can be accessed as follows: An audio replay of the conference call will be available from approximately 11:30 am ET on May 5, 2021, until 11:59 pm ET on May 19, 2021, and can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international), and providing the passcode 13719094 or by accessing Intermex’s website at https://investors.intermexonline.com/.  About International Money Express, Inc.At International Money Express, Inc. (NASDAQ: IMXI), the customer is at the center of everything...

Continue reading

MacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call

ROCKVILLE, MD, April 19, 2021 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2021 after the market closes on Thursday, April 29, 2021. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, April 29, 2021 at 4:30 pm ET. The conference call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the Conference ID# 5257004. The listen-only webcast of the conference call can be accessed under “Events & Presentations” in the...

Continue reading

A. H. Belo Corporation Announces Schedule for First Quarter 2021 Financial Results Release and Conference Call

DALLAS, April 19, 2021 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) said today that it will release first quarter 2021 financial results before the market opens on Tuesday, April 27, 2021. A conference call will be held on Tuesday, April 27, 2021 at 9:00 a.m. CDT. The conference call will be simultaneously webcast on A. H. Belo Corporation’s website at www.ahbelo.com/invest. An archive of the webcast will be available at www.ahbelo.com in the Investor Relations section. To access the listen-only conference call, dial 1-877-226-8189 and enter the following access code when prompted: 5840199. A replay line will be available at 1-866-207-1041 from 12:00 p.m. CDT on April 27, 2021 until 11:59 p.m. CDT on May 3, 2021. The access code for the replay is 8305657. About A. H. Belo Corporation A. H. Belo Corporation is the leading...

Continue reading

MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit

LONDON and NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, and Stuart Naylor, Ph.D., chief development officer, will participate in a fireside chat at the Chardan Virtual Genetic Medicines Manufacturing Summit on Monday, April 26, 2021 at 1:45 p.m. ET. A live webcast of the presentation will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 90 days following the presentation. About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical...

Continue reading

Conformis Announces License Agreement with Paragon 28

BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis’ U.S. patents for the use of patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D™ Total Ankle Replacement System. “We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering,” said Mark Augusti, President and Chief Executive Officer. “We believe that this latest license agreement further demonstrates the broad applicability and clinical appeal of Conformis’ technology.” About Conformis, Inc. Conformis is a medical technology company that uses its proprietary...

Continue reading

Purpose Investments Inc. Announces April Distributions

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the following distributions for the month of April 2021. The ex-distribution date for all ETFs is April 27, 2021, with the exception of Purpose High Interest Savings ETF and Purpose US Cash Fund, which have an ex-distribution date of April 29, 2021. The ex-distribution date for all closed-end funds is April 29, 2021. Open-End Funds TickerSymbol Distributionper share/unit RecordDate PayableDate DistributionFrequency Purpose Core Dividend Fund – ETF Series PDF $0.08501 04/28/2021 05/07/2021 Monthly Purpose Enhanced Dividend Fund – ETF Series PDIV $0.05221 04/28/2021 05/07/2021 Monthly Purpose Total Return Bond Fund – ETF Series PBD $0.05201 04/28/2021 05/07/2021 Monthly Purpose Real Estate Income Fund – ETF Series PHR $0.07201 04/28/2021 05/07/2021 Monthly Purpose...

Continue reading

Wintrust Financial Corporation Reports Record First Quarter 2021 Net Income of $153.1 million

ROSEMONT, Ill., April 19, 2021 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced record net income of $153.1 million or $2.54 per diluted common share for the first quarter of 2021, an increase in diluted earnings per common share of 56% compared to the fourth quarter of 2020 and an increase of 144% compared to the first quarter of 2020. Highlights of the First Quarter of 2021:Comparative information to the fourth quarter of 2020 Total assets increased by $601 million. Total loans, excluding Paycheck Protection Program (“PPP”) loans, increased by $515 million. Originated $1.3 billion of PPP loans in the first quarter of 2021 which generated fees of $51.2 million, net of $1.8 million of deferred costs, to be recognized over the...

Continue reading

CNB Financial Corporation Reports First Quarter 2021 Earnings Per Share of $0.78 Compared to $0.57 for First Quarter 2020

CLEARFIELD, Penn., April 19, 2021 (GLOBE NEWSWIRE) — CNB Financial Corporation (“CNB” or the “Corporation”) (NASDAQ: CCNE), the parent company of CNB Bank, today announced its earnings for the quarter ended March 31, 2021. Joseph B. Bower, Jr., President and CEO, stated, “We are pleased to report a strong earnings quarter to you. The initiatives we implemented in 2020, due to our level of excess liquidity, are working out as planned. During the first quarter, we continued to support our local businesses by participating in the second round of the Paycheck Protection Program. As we look forward, we have a positive outlook for the remainder of the year, as business growth opportunities improve, especially in our newest region in Northeast Ohio, where we just broke ground on a new branch location in the Cleveland area. Plans are already...

Continue reading

BankFinancial Corporation Reports Financial Results for the First Quarter 2021 and Will Host Conference Call and Webcast on Wednesday, April 21, 2021

BURR RIDGE, Ill., April 19, 2021 (GLOBE NEWSWIRE) — BankFinancial Corporation (Nasdaq – BFIN) (the “Company”) reported net income for the three months ended March 31, 2021 of $1.5 million, or $0.10 per common share, compared to net income of $2.4 million, or $0.16 per common share, for the three months ended March 31, 2020.  At March 31, 2021, BankFinancial had total assets of $1.620 billion, total loans of $1.029 billion, total deposits of $1.422 billion and stockholders’ equity of $171 million. Total net loans increased by $26.3 million for the quarter ended March 31, 2021, primarily due to continued strong originations of commercial equipment finance transactions and increased utilization of commercial lessor finance lines of credit.  Total commercial loans and leases increased by $37.6 million (9.3%) for the quarter ended...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.